77χρονη με επαναλαμβανόμενα ισχαιμικά εγκεφαλικά: «Τι μου ξεφεύγει…;» Γεώργιος Ντάιος Παθολογική Κλινική, Πανεπιστήμιο Θεσσαλίας
Disclosures Scholarships: European Stroke Organization; Hellenic Society of Atherosclerosis. Honoraria: Medtronic; Quintiles; CHUV; Belgian Stroke Council; Boehringer-Ingelheim. Speaker fees: Sanofi; Boehringer-Ingelheim; Galenica; Elpen; Bayer Support to attend conferences: Bayer; Sanofi-Aventis; Pfizer; Lundbeck; Boehringer-Ingelheim; Galenica; Elpen; Bristol Myers Squibb. Participation in trials: NAVIGATE-ESUS / Steering Committee member, National Coordinator (Greece) & Principal Investigator (Larissa) PRECIOUS / National Coordinator (Greece) & Executive Committee member. ENOS / National Coordinator (Greece). FOURIER / Principal investigator (Larissa). GLORIA-AF / Sub-investigator (Larissa). EBBINGHAUS / Principal Investigator (Larissa). BIOSIGNAL / Principal Investigator (Larissa). PREVISE / Principal investigator (Larissa). Most relevant disclosure
♀, 77yrs Right dense hemiplegia (3hrs) Face/arm/leg No sensory deficit No aphasia Hypertension, DM (HbA1c: 8.4%) AF (Acenocoumarol) / INR: 1.5
Transient ischemic attack September Transient ischemic attack September Change to Dabigatran 150 January Stroke November Carotid triplex Second TIA we order a triplex carotids ok November 2nd Transient ischemic attack
TOAST classification 5 κατηγορίες, οι εξής 3
Small vessel disease Pure motor Pure sensory
Right dense hemiplegia Face/arm/leg No sensory deficit No aphasia
Small vessel disease - lipohyalinosis
Small vessel disease - causes
Small vessel disease: not only in brain
If I could turn back time…. «Θα μπορούσατε να είχατε θέσει γρηγορότερα τη διάγνωση;» Ναι, αν: διάβαζα περισσότερο. είχα πάει στο Συνέδριο της ΕΠΒΕ.
If I could turn back time…. «Τι θεραπεία θα είχατε δώσει;» Το ίδιο αντιθρομβωτικό. Καλύτερη ρύθμιση ΑΥ & ΣΔ.
Take-home messages
Welcome